Clinical Fellowships for ATTR Amyloidosis supports institutional programs that train physicians in disease diagnosis, treatment, and research to improve early recognition and patient-centered care.
The Cardiac Amyloid Fellowship at Mayo Clinic provides intensive clinical and research training in cardiac amyloidosis, emphasizing multidisciplinary care and advanced imaging.
Alnylam Pharmaceuticals' Sponsorships fund educational and scientific initiatives advancing research and awareness in ATTR amyloidosis, AHP, and PH1.
Educational Grants - Alnylam Pharmaceuticals support healthcare professionals and patients through independent education on three rare diseases to advance earlier diagnosis, treatment decisions, and disease management.
Alnylam Pharmaceuticals' CME Grants fund independent, evidence-based education for healthcare professionals on ATTR amyloidosis, AHP, and PH1.
Responses to Requests for Proposals supports organizations delivering independent education for healthcare professionals and patients to address knowledge gaps and improve care in ATTR amyloidosis, AHP, and PH1.